Skip to main content
. 2013 Jun 19;54(6):4197–4207. doi: 10.1167/iovs.13-11608

Figure 2.

Figure 2

The effect of GW0742 and GSK0660 on HRMEC proliferation. (A) GW0742 exhibited no effect on HRMEC proliferation. GSK0660 treatment led to a dose-dependent reduction of serum-induced proliferation. (B) GSK0660 treatment results in a dose-dependent reduction of VEGF-induced proliferation. Each bar represents the mean ± SEM.